| CTYCX | FDFCX | CTYCX / FDFCX | |
| Total Expense Ratio | 1.44 | 0.41 | 351% |
| Annual Report Gross Expense Ratio | 1.44 | 0.41 | 351% |
| Fund Existence | 14 years | 6 years | - |
| Gain YTD | 1.396 | 2.109 | 66% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.34B | 5.34B | 100% |
| Annual Yield % from dividends | 2.46 | 3.35 | 73% |
| Returns for 1 year | 0.41 | 1.51 | 27% |
| Returns for 3 years | 23.06 | 26.92 | 86% |
| Returns for 5 years | -0.11 | 5.36 | -2% |
| Returns for 10 years | 28.01 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MUXYX | 31.42 | 0.27 | +0.87% |
| Victory S&P 500 Index Y | |||
| HWSCX | 69.48 | 0.59 | +0.86% |
| Hotchkis & Wiley Small Cap Value C | |||
| JEMCX | 50.06 | 0.31 | +0.62% |
| JPMorgan Emerging Markets Equity C | |||
| LYFAX | 18.53 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare A | |||
| CEMFX | 20.11 | -0.16 | -0.79% |
| Cullen Emerging Markets High Div I | |||